Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

OPPS 2003 Proposed Rule Contains Payment Cuts For 80% Of Devices – Scully

This article was originally published in The Gray Sheet

Executive Summary

Ambulatory payment classification 0107 (insertion of cardioverter-defibrillator leads) faces a 51% payment rate reduction compared with its 2002 reimbursement level, according to the hospital outpatient prospective payment system (OPPS) proposed rule for 2003

You may also be interested in...



Hospital Revenue Coding Relevance Rises With Sunset Of C-Codes

Reimbursement for new medical technologies increasingly will depend on the creation or modification of hospital revenue codes, as CMS continues to limit the availability of outpatient "pass-through" codes, according to Boston Scientific Director of Health Policy and Payment Sarah Wells

Hospital Revenue Coding Relevance Rises With Sunset Of C-Codes

Reimbursement for new medical technologies increasingly will depend on the creation or modification of hospital revenue codes, as CMS continues to limit the availability of outpatient "pass-through" codes, according to Boston Scientific Director of Health Policy and Payment Sarah Wells

2003 OPPS Final Rule Alleviates Payment Reductions For Device Procedures

Medicare's hospital outpatient prospective payment system (OPPS) reimbursement rate for APC 0107 (insertion of cardioverter defibrillators) will decrease by 12% under the 2003 final rule, released Nov. 1

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT017007

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel